Live from the NIH registry
Studies recruiting near Albany right now
Top 25 of 201 recruiting studies, sorted by proximity — each links to its official registry page
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Children's Hospital of Philadelphia
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Novo Nordisk A/S
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Steba Biotech S.A.
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Medtronic Cardiovascular
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Zucara Therapeutics Inc.
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Yale University
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Albany, New York (2.4 mi)
· Sponsor: Sameek Roychowdhury
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Sparrow Pharmaceuticals
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
New York Oncology Hematology, P.C. — Albany, New York (2.4 mi)
· Sponsor: US Oncology Research
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 750 participants sought
Research Site — Albany, New York (2.4 mi)
· Sponsor: AstraZeneca
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Albany, New York (2.4 mi)
· Sponsor: Medtronic
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF)
Phase 3
Interventional 460 participants sought
New York Oncology Hematology P C — Albany, New York (2.4 mi)
· Sponsor: Novartis Pharmaceuticals
Quality of End-of-Life Care for Children With Cancer
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
N/A
Observational 2,425 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Children's Oncology Group
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)
Phase 3
Interventional 124 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: VectivBio AG
Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children
Nocturnal Enuresis, Bedwetting
N/A
Interventional 70 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Albany Medical College
Global Paradise System US Post Approval Study
Hypertension, Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: ReCor Medical, Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Albany Medical College- Endocrinology Washington Extension /ID# 256794 — Albany, New York (2.4 mi)
· Sponsor: AbbVie
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Mercy Health Ohio
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Albany, New York (2.4 mi)
· Sponsor: AstraZeneca
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0511 — Schenectady, New York (12.5 mi)
· Sponsor: Bristol-Myers Squibb
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Ellis Hospital ( Site 0098) — Schenectady, New York (12.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Ellis Hospital — Schenectady, New York (12.5 mi)
· Sponsor: Mirati Therapeutics Inc.